UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 3,536	$ 3,217
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	166	149
Amortization	508	592
Provision for (recovery of) losses on accounts receivable	(1)	(13)
Deferred income taxes	(118)	(117)
Stock-based compensation expense	36	21
Tax benefit attributable to exercise of stock options	10	19
Changes in operating assets and liabilities:
Accounts receivable	(934)	(782)
Accrued interest and other receivables	(5)	(16)
Inventories	(154)	(133)
Prepaid expenses and other current assets	(56)	(45)
Accounts payable	117	337
Accrued expenses	1,202	923
Total adjustments	771	935
Net cash provided by operating activities	4,307	4,152
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(65)	(48)
Capital expenditures for intangible assets		(4)
Net cash provided by (used in) investing activities	(65)	(52)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	53	148
Payment of dividends	0	0
Net cash provided by (used in) financing activities	53	148
Effect of exchange rate changes on cash	88	(10)
Net increase (decrease) in cash and cash equivalents	4,383	4,238
Cash at beginning of period	26,296	23,278
Cash at end of period	30,679	27,516
Cash paid during the period for income taxes	442	345
Cash paid during the period for interest	$ 0	$ 0